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Purpose: Lentivirus-mediated gene transfer is an important approach to modify the function of progenitor cells in ex vivo
gene therapy, but may be susceptible to downregulation due to transcriptional silencing. The purpose of this study was to
analyze the stability of lentivirus-mediated transgene expression in undifferentiated and differentiated retinal progenitor
cells (RPCs), and to characterize the effect of lentivirus transduction on RPC differentiation in vitro.
Methods: RPCs derived from postnatal day 1 mice were expanded in defined serum-free culture medium and transduced
with nonprimate lentiviral vector of feline immunodeficiency virus (FIV) expressing yellow fluorescent protein (YFP)
reporter. Long-term expression of YFP in undifferentiated and differentiated RPCs was analyzed. Expression of various
markers for RPCs and differentiated cells was analyzed by immunochemical staining in lentivirus-transduced and control
RPCs. Differentiated postmitotic cells were revealed by negative labeling of bromodeoxyuridine (BrdU).
Results: FIV transduction induced long-term expression of YFP reporter in RPCs for up to 53 days (10 passages) with
no sign of decrease in expression level. FIV transduction did not alter the expression profile of various markers in retinal
spheres, including nestin, microtubule-associated protein 2 (MAP-2), glial fibrillary acidic protein (GFAP), and opsin.
However, YFP expression was downregulated in differentiated BrdU-negative postmitotic cells.
Conclusions: FIV-mediated long-term expression of transgene in undifferentiated RPCs is downregulated upon their
differentiation. Thus, lentivirus-mediated ex vivo modulation should be cautiously analyzed for transgene expression not
only in undifferentiated RPCs, but also in differentiated postmitotic cells.
Retinal  progenitor  cells  (RPCs)  are  multipotent
precursors that can give rise to different types of retinal cells
and thus hold the potential to be used to treat degenerative
retinal diseases by cell replacement therapy [1-4]. RPCs are
typically isolated from the retina or ciliary margin and have
the ability to maintain their proliferative capacity in vitro.
RPCs have many similar characteristics to neural progenitor
cells (NPCs). Both cell types can grow in the same culture
conditions supplemented with growth factors, form clonal
spheres with similar morphology, and express the progenitor
marker  nestin.  However,  RPCs  isolated  from  the  ciliary
margin are independent of exogenous basic fibroblast growth
factor  (bFGF)  by  supplementing  their  own  bFGF  in  an
autocrine fashion [5]. RPCs have the capacity to differentiate
into unique cell lineages expressing retina-specific markers,
such as opsin for photoreceptors.
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Genetic engineering of progenitor cells with viral vectors
followed by in vivo transplantation (ex vivo gene therapy) has
multiple  potential  applications,  including  delivery  of
therapeutic  proteins  and  modulation  of  progenitor  cell
differentiation and function [6]. One of the challenges for gene
transfer with lentiviral or retroviral vectors is potential loss of
transgene expression after transplantation [7-9], even though
the transplanted cells may survive and integrate well into host
tissues.  Because  previous  studies  have  suggested  that
lentiviral vectors may be more resistant to stem cell-specific
gene silencing in various types of stem cells [10,11], we were
interested  in  the  possible  silencing  of  lentivirus-mediated
transgene expression. Feline immunodeficiency virus (FIV)
is of particularly interest because of safety concerns [12,13].
Unlike  human  immunodeficiency  virus  (HIV)-based
lentiviral vectors, FIV vectors are derived from a nonhuman
pathogen.  Routine  exposure  to  FIV  fails  to  induce
seroconversion or disease in humans. A legitimate concern for
the use of HIV vectors in human subjects is the potential for
vector mobilization following HIV infection. However, the
mobilization of a second or third generation of FIV-based
vectors by HIV gag and pol proteins has not been detected
[13]. This lack of significant cross-packaging of FIV vectors
by  HIV  makes  FIV  vectors  attractive  vehicles  for  gene
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2117delivery  to  stem  cells,  including  RPCs.  The  ability  of
retroviral and lentiviral vectors to induce stable transgene
expression  in  RPCs  has  not  been  defined,  and  possible
downregulation  of  transgene  expression  in  differentiated
RPCs is yet to be characterized. A recent report of transgene
silencing by retrovirus- and lentivirus-mediated gene transfer
in differentiated NPCs [14] prompted us to examine FIV-
mediated  long-term  transgene  expression  in  RPCs  and
possible silencing in differentiated cells in this study.
Here we used a second generation FIV vector to drive the
expression  of  yellow  fluorescent  protein  (YFP)  in  RPCs.
Stable  transgene  expression  in  FIV-transduced  RPCs  was
demonstrated.  However,  the  transgene  expression  was
downregulated in differentiated bromodeoxyuridine (BrdU)-
negative  postmitotic  cells,  suggesting  that  FIV-mediated
transgene expression is also subjected to the transcriptional
silencing  in  RPCs,  similar  to  the  HIV-based  lentivirus
silencing previously reported in NPCs [14].
METHODS
RPC isolation and expansion: RPCs were isolated from the
neural retina of C57BL/6 mice (The Jackson Laboratory, Bar
Harbor, ME) at postnatal day 1, as previously described [15].
Animal procedures were conducted in accordance with the
National Institutes of Health Animal Care and Use Committee
protocols. The periphery of the retina and the optic nerve stalk
were removed. Retinal tissue was dissected and digested for
1 h in Dulbecco's Modified Eagle's Medium (DMEM)/F-12
(Invitrogen,  Carlsbad,  CA)  containing  0.1%  collagenase
(Sigma,  St.  Louis,  MO).  Cells  were  subsequently  filtered
through a 40 µm nylon mesh (BD Bioscience, Bedford, MA),
centrifuged,  and  resuspended  in  DMEM/F-12  media
supplemented  with  10%  FBS,  100  µg/ml  N-2  neural
supplement (Invitrogen), 100 µg/ml penicillin/streptomycin,
2 mM L-glutamine, and 1 µg/ml fungizone. Cells were then
incubated at 37 °C. After reaching confluence within a week,
cells were trypsinized with 0.1% trypsin-EDTA (Invitrogen),
washed with phosphate buffered saline (PBS, resuspended in
serum-free DMEM/F-12 media supplemented with N-2, 20
ng/ml epidermal growth factor (EGF) (Sigma) and 20 ng/ml
bFGF (Sigma). Cells were incubated at 37 °C until retinal
spheres were formed and propagated. RPC spheres were split
every 5–7 days with NeuroCult Chemical Dissociation kit
(StemCell Technologies, Vancouver, BC, Canada) according
to  the  manufacturer’s  protocol  with  minor  modifications.
Briefly, the volumes of solutions B and C in the kit were
doubled during cell passaging to improve RPC dissociation
for clonogenic culture. This modified protocol can efficiently
dissociate RPCs with more than 95% viability. Dissociated
RPCs were plated at roughly 200 cells/ml for clonogenic
expansion and split when the cell density at approximately
20,000 cells/ml (about 5–7 days).
Lentiviral infection: Second-generation FIV-based lentiviral
vectors were gifts from Dr. Garry Nolan (Stanford University,
Stanford, CA) [13,16]. Information for pFIV-YFP (pLionII-
YFP; Figure 1A) and other packaging plasmids are available
at  FELIX.  For  FIV  production,  viral  supernatants  were
generated by cotransfecting 293T cells with 3.75 µg pFIV-
YFP, 4.5 µg pCI-VSVG, and 6.25 µg pCPRΛEnv plasmids in
100 mm culture plates by calcium phosphate precipitation.
FIV-YFP in Opti-MEM medium (Invitrogen) supplemented
with 1% FBS was collected every 12 h between 36 h to 60 h
posttransfection. FIV titer was determined by infecting fresh
293T cells with FIV-conditioned medium in serial dilutions.
FIV-infected yellow fluorescent protein (YFP)-positive cells
were analyzed by flow cytometry analysis two days after the
infection. A typical titer for FIV-conditioned medium was
approximately 1×106 pfu/ml. Before infection, RPCs were
dissociated,  and  the  resultant  single  cell  suspension  was
incubated  for  6  h  with  filtered  lentivirus-containing
supernatants  at  approximately  20  multiplicity  of  infection
(MOI) supplemented with 1 μg/ml polybrene (Sigma). YFP
expression was analyzed using a Olympus fluorescence IX50
inverted  fluorescence  microscope  (Olympus  100W
fluorescence  light  source  and  the  filter  set  for  Exciter  at
D480/30x and Emitter at D535/40m; Olympus, Center Valley,
PA),  and  flow  cytometry.  All  the  results  in  this  study
represented at least three independent experiments starting
from FIV infection.
Flow cytometry analysis: RPCs infected with lentivirus were
chemically dissociated as described in the previous section
and  washed  once  in  PBS.  Fluorescence-activated  flow
cytometry  was  performed  with  a  FACScan  2000  flow
cytometer (Becton Dickinson, Franklin Lakes, NJ). A total of
5,000 events were analyzed for each sample. Live cells were
gated for analysis based on forward angle light scatter (FSC)
and side angle light scatter (SSC) with laser excitation at 488
nm and emission filter at 530/30. Single-color analysis was
performed with CellQuest software (Becton Dickinson).
RPC differentiation: For differentiation, retinal spheres were
dissociated by the modified chemical dissociation method
described above to obtain single-cell suspension. Cells were
seeded at a concentration of 1×105 cells/ml in 12 well culture
plates  on  glass  coverslips  coated  with  poly-D-lysine  and
laminin (Sigma), in basic medium in the absence of bFGF and
EGF growth factors and supplemented with 5% FBS. The
culture medium was changed every 2–3 days, and cells were
allowed to differentiate for up to 2 weeks. RPCs were labeled
by incubating with 10 μM BrdU (Sigma) in growth medium
for 48 h and analyzed by immunocytochemistry.
Immunocytochemistry: The expression patterns of various cell
lineage  markers  were  analyzed  using  the  following
antibodies:  1:100  dilution  mouse  anti-nestin  mAb  for
undifferentiated precursors (Chemicon), 1:500 anti-MAP-2
(microtubule-associated protein 2) mAb for mature neurons
(Chemicon),  1:100  anti-opsin  mAb  for  photoreceptors
(Sigma),  1:800  anti-GFAP  (glial  fibrillary  acidic  protein)
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proliferating  cells  with  incorporated  BrdU  (Zymed
Laboratories).
Cells were fixed in ice-cold 4% paraformaldehyde in PBS
and  washed  twice  with  ice-cold  PBS.  Cells  were
permeabilized with 0.2% Triton-X, and nonspecific binding
sites  were  blocked  using  10%  donkey  serum.  To  label
intracellular protein markers, we incubated cells with primary
mAb in PBS/0.1% Triton-X for 1 h at room temperature,
followed by 45 min incubation with rhodamine-conjugated
donkey anti-mouse IgG antibody (Jackson ImmunoResearch,
West Grove, PA). Nuclei were counterstained with 1 μg/ml
4',6-diamidino-2-phenylindole (DAPI). The coverslips were
mounted  onto  glass  slides  using  water-based  Aqua-
PolyMount media (Polyscience). Samples were analyzed by
Leica TCS SP5 confocal microscopy with diode laser for
excitation at 405 nm and emission at 480 nm for DAPI, argon
laser excitation at 488 and emission at 510–570 nm for YFP,
and HeNe laser excitation at 543 nm and emission at 600–680
nm for rhodamine. Alternatively, samples were analyzed by
Zeiss  Axiovert  200  m  fluorescence  microscope  with  a
mercury 100 W fluorescence light source (Zeiss, Thornwood,
NY), which had 47% of the radiant output from a Zeiss HBO
100 lamp lies between the wavelengths of 320 and 700 nm.
The filter set for DAPI was excitation 365, beam splitter FT
395, and emission BP 445/50; the filter set for YFP was
excitation BP 475/40, beam splitter FT 500, and emission
530/50; and the filter set for rhodamine was excitation BP
565/30, beam splitter FT 585, and emission BP 620/60. For
each  immunostaining,  at  least  100  cells  were  counted  to
determine the percentage of cells with positive signal.
RESULTS
Long-term  expression  of  YFP  reporter  in  undifferentiated
RPCs: Cells isolated from mouse retina at postnatal day 1
were cultured as a monolayer in FBS-supplemented medium
until they reached confluence. When cells were switched to
FBS-free mitogen-containing medium, retinal spheres formed
that showed positive staining for progenitor cell marker nestin
(Figure  2).  The  RPCs  exhibited  clonogenic  proliferation
capacity (clonality; Figure 3) and the ability to give rise to
multiple cell lineages (multipotentiality; Figure 4).
FIV is a nonprimate lentivirus capable of infecting both
dividing and nondividing cells [13]. It is also able to integrate
Figure 1. Lentivirus transduction of retinal progenitor cells. A: Schematic representation of feline immunodeficiency virus (FIV) vector.
Abbreviations are: LTR, FIV long-terminal repeat; CMV, human cytomegalovirus promoter, and YFP, yellow fluorescent protein. B: In vitro
live fluorescence image of retinal progenitor cells (RPCs) spheres for yellow fluorescent protein (YFP) expression (top, fluorescence field;
bottom, bright field). RPCs were transduced with FIV-YFP and analyzed for YFP expression at day 8 post-transduction with an Olympus
IX50 inverted fluorescence microscope. C: Flow cytometry analysis of YFP expression in RPCs. Flow cytometric histogram of control cells
(filled gray histogram) and FIV-YFP transduced cells (open black line) from representative experiment is shown. At least 5,000 gated cells
were analyzed for YFP expression. The majority of FIV-transduced RPCs (97.5%) were YFP positive.
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2119transgene of interest into the host chromosome for long-term
expression. In the present study, FIV efficiently transduced
high levels of YFP expression in more than 97.5% of RPCs
(Figure 1). Sustained transgene expression of YFP reporter
was detected up to 53 days and 10 passages in culture, with
no sign of decrease in expression (Figure 3). FIV transduction
neither altered the expression pattern of nestin (Figure 2), nor
affected the differentiation capacity of RPCs to other cell
lineages  (Figure  4).  Cell  types  generated  by  RPC
differentiation were analyzed by immunocytochemistry for
cell-specific marker expression, including MAP-2 for mature
neurons, opsin for photoreceptors, and GFAP for glial cells
(Figure 4A). No difference was observed in the percentage of
cells positive for those markers between FIV-YFP transduced
and control cells (Figure 4B). In addition, FIV transduction
did not affect RPC growth rate (data not shown). These results
Figure 2. Nestin expression in FIV-transduced retinal progenitor cells. A: Immunocytochemistry for nestin expression (red signal) in retinal
progenitor cell (RPC) spheres cultured under proliferating conditions. The nuclei of all cells were stained with DAPI (blue signal) and analyzed
using a Zeiss Axiovert 200 m fluorescence microscope. B: Quantitative analysis of nestin-positive cells in feline immunodeficiency virus
(FIV) for yellow fluorescent protein (YFP)-infected and noninfected RPCs. The percentage of nestin-expressing cells was determined by
counting at least 100 cells in three independent experiments. Results are expressed as mean±SEM; p<0.05 (Student’s t-test; FIV-YFP versus
control).
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2120indicated that FIV transduction induced strong and stable
transgene expression without affecting RPC self-renewal and
differentiation capacities.
Loss  of  YFP  reporter  expression  in  differentiated  RPCs:
Because  of  a  previous  report  of  the  loss  of  transgene
expression  in  lentivirus-  and  retrovirus-transduced  NPCs
[14], it was important to analyze FIV-mediated transgene
expression in differentiated RPCs. Downregulation of YFP
expression was observed mostly in differentiated cells that
exhibited attachment and extended cellular processes (Figure
5A). All the cells expressing a high level of YFP lacked
extended  cellular  processes.  During  normal  RPC
differentiation,  RPCs  lose  their  self-renewal  capacity  and
emerge as differentiated postmitotic retinal cell lineages, such
as  retinal  ganglion  cells,  photoreceptors,  and  Müller  glial
cells. To delineate the correlation between cell proliferation
capacity  and  transgene  downregulation,  we  labeled
proliferating cells with BrdU. The results revealed that BrdU-
positive RPCs had a high level of YFP expression, while
transgene  expression  was  substantially  downregulated  in
BrdU-negative cells (Figure 5B). These data suggested that
the loss of YFP expression occurred only in differentiated
postmitotic cells.
DISCUSSION
Gene transfer into multipotent progenitor cells is an integral
part of ex vivo gene therapy, which has been shown to be able
to  successfully  halt  or  delay  the  progression  of  neural
degenerative  diseases  or  to  treat  various  pathological
conditions [17,18]. Retroviral and lentiviral vectors have been
widely used for ex vivo gene therapy because they are able to
integrate  into  the  host  chromosomes  for  long-term  gene
expression [19]. It is anticipated that genetically engineered
progenitor cells, after implantation, may differentiate toward
distinct cell lineages to replace the degenerated cells. Stable
expression of transgenes in undifferentiated progenitor cells,
and—more important—in differentiated cells, represents an
important prerequisite for successful ex vivo gene therapy.
Gene silencing is a general term encompassing several
related phenomena. The most dramatic effect was reported
about 30 years ago when murine leukemia virus (MLV) was
subjected to complete transcriptional silencing after being
introduced into embryonic carcinoma cells [20,21]. A less
well known fact is that retrovirus vectors are also susceptible
to "extinction", a term that refers to the progressive silencing
of an initially expressed transgene during long-term culture or
differentiation [22].
Retroviral  silencing  has  been  attributed  to  reduced
transcriptional initiation at the promoter that can be caused by
the binding of trans-acting factors to silencer elements in the
viral  long-terminal  repeats  (LTRs)  [8,9].  Chromatin
condensation caused by de novo cytosine methylation of CpG
sequences located within LTRs may contribute to transgene
silencing  as  well  [23,24].  Histone  deacetylation  of  the
integrated  transgenic  DNA  was  suggested  to  be  partially
responsible for the decrease [9,25]. The construction of viral
Figure 3. Long-term expression of YFP reporter in FIV-transduced RPCs. Dissociated RPCs were transduced with feline immunodeficiency
virus (FIV) expressing yellow fluorescent protein (YFP) and plated at a low density of 10 cells/μl in the complete growth medium to generate
clonal spheres. Cells were monitored, and images captured at days 1, 4, and 7 post-dissociation by the inverted fluorescence microscope to
detect the presence of secondary RPC spheres. Long-term expression of YFP reporter was still detected after 10 passages. Shown are live-
phase contrast cell images (fluorescence and bright field) from the representative culture.
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2121vectors lacking silencer elements, the inclusion of improved
positive regulatory elements, and the use of internal promoters
have been reported to improve duration of gene expression
[8]. Inserting a copy of DNA insulator into LTRs of an HIV-
based  lentiviral  vector  can  prevent  enhancer-promoter
interactions and protect transgenic expression cassettes from
silencing and positional effects [26-28]. However, a previous
study showed that an insulator was only able to partially
protect against differentiation-dependent downregulation of
HIV-based transgene expression in NPCs, both in vitro and in
vivo, but not progressive transgene silencing in proliferating
cells  [29].  These  results  suggest  that  the  mechanism  for
progressive  silencing  is  different  from  the  one  for
differentiation-dependent silencing. Our study revealed that
although  progressive  loss  of  FIV-mediated  transgene
expression  was  not  detected  in  undifferentiated  RPCs,
differentiation  induced  substantial  loss  in  transgene
expression. It has yet to be determined whether the insertion
of an insulator in FIV LTR may protect against differentiation-
dependent silencing in RPCs.
Transgene  expression  may  also  be  downregulated  by
other  mechanisms.  For  example,  the  cytomegalovirus
promoter has been shown to be vulnerable to silencing due to
DNA methylation [30]. Previous investigations indicated that
Figure 4. Multipotentiality. A: Retinal progenitor cells (RPCs) transduced with feline immunodeficiency virus (FIV) for yellow fluorescent
protein (YFP) were cultured under differentiated conditions for 14 days to give rise to neuronal and glial cell types. Cells that stained positive
for microtubule-associated protein 2 (MAP-2), opsin, and glial fibrillary acidic protein (GFAP) were analyzed by confocal microscopy, and
signaling displayed in red. Green signal was YFP, and blue signal was DAPI staining for nuclei. B: Quantitative analysis of cells positive for
MAP-2, opsin, and GFAP in RPC group infected with or without FIV-YFP. At least 100 cells were counted from three independent experiments.
Results are expressed as mean±SEM; p>0.05 (Student’s t-test; FIV-YFP versus control).
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2122different cellular and viral promoters exhibited distinct and
dynamic properties not only in terms of promoter strength but
also  with  respect  to  differentiation  stage-specific  activity
[31]. Thus, it is necessary to thoroughly examine and compare
different promoters for optimal transgene expression in RPCs.
Other possible explanations for the loss of YFP signal
may include changes in translation efficiency in a new cellular
environment due to RPC differentiation or “dilution” of YFP
signal in the differentiated RPCs with larger cellular areas.
Although less likely, these possibilities cannot be completely
eliminated.
RPCs share many similarities to NPCs. Both derive from
neural tissues, grow as spheres in similar defined serum-free
culture media, and are capable of giving rise to similar, but
distinct, neural cell lineages. Although transgene silencing by
MLV-based retroviral vector and HIV-based lentiviral vector
has  been  well  documented  in  NPCs,  it  has  not  been
documented for FIV-based lentiviral vector. Because of the
similarities between RPCs and NPCs, a previous report of
transgene  silencing  in  differentiated  NPCs  transduced  by
MLV-based  retroviral  vectors  and  HIV-based  lentiviral
vectors raised the possible concern of transgene silencing in
RPCs  [14].  Our  findings  indicated  that  FIV  transduction
induced long-term transgene expression in undifferentiated
RPCs. Yet, differentiation of RPCs was accompanied by a
rapid loss of YFP expression, indicating a close relationship
between RPC differentiation and transgene silencing. The loss
of YFP expression in differentiated RPCs was likely due to
transcriptional  silencing  that  was  previously  reported  for
retroviral and lentiviral vectors. Intriguingly, previous studies
showed  that  direct  in  vivo  injection  of  lentiviral  vectors
resulted in stable reporter expression in differentiated neurons
and glia for up to 16 months [14]. Moreover, a recent study
by Rompani and Cepko [32] showed that Moloney Murine
Leukemia  viral  (MMLV)  vector  and  HIV-based  lentiviral
vector efficiently transfected chick retinal progenitor cells or
determined  progenitor  cells  in  ovo.  The  differentiated
horizontal  cell  lineages  remained  reporter-positive.  The
discrepancy could be due to the uniqueness related to FIV, or
it may have been caused by in vitro culture conditions, such
as  long-term  culture  after  the  FIV  infection.  Our  results
suggested that development of any future ex vivo gene therapy
Figure 5. YFP expression in differentiated retinal progenitor cells. A: Live images of FIV-YFP infected cells cultured for 14 days under
differentiated conditions from a representative experiment. The cells have adopted a variety of neuronal cell morphologies and have
downregulated the expression of YFP (arrows). B: Immunocytochemistry of cells labeled with BrdU (red signal) and cultured under
differentiating conditions. BrdU-negative cells downregulated the expression of YFP (arrows). The nuclei of all cells were stained with DAPI
(blue signal). The results were examined using a Zeiss Axiovert fluorescence microscope, and images from the representative experiments
are shown.
Molecular Vision 2008; 14:2117-2125 <http://www.molvis.org/molvis/v14/a248> © 2008 Molecular Vision
2123using RPCs, especially with lentiviral or retroviral vectors,
should pay special consideration to transgene silencing not
only in undifferentiated progenitors, but also in differentiated
cells.
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